• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

程序性死亡配体 1 在癌相关成纤维细胞对晚期喉鳞状细胞癌的影响。

Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.

机构信息

Department of Otolaryngology, 74566The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Otolaryngology, Suzhou Ninth Hospital affiliated to Soochow University, Suzhou, China.

出版信息

Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211046432. doi: 10.1177/15330338211046432.

DOI:10.1177/15330338211046432
PMID:34632870
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8504221/
Abstract

This study aimed to explore the effect of programmed death-ligand 1 (PD-L1) in cancer-associated fibroblasts (CAFs) on advanced laryngeal squamous cell carcinoma (LSCC). The expression of PD-L1 in advanced LSCC tumor tissues was observed in 83 patients with LSCC by immunofluorescence microscopy and compared with that in normal laryngeal mucosa. The CAFs of LSCC and normal fibroblasts (NFs) were isolated, cultured, purified, and examined by fluorescence. The expression of PD-L1 in purified CAFs and NFs was measured by flow cytometry. The expression of PD-L1 in CAFs was downregulated through small interferring RNA (siRNA) transfection. The proliferation and migration capacities of CAFs were observed using proliferation and scratch tests, respectively. The proliferation of HEP-2 cells and T cells was measured after cocultured with CAFs. The secretion of interleukins IL-2 and IL-10 was detected using enzyme-linked immuno sorbent assay (ELISA). PD-L1 was expressed in 62 of 83 cases of the advanced LSCC tumor tissues. Also, CAFs expressed more PD-L1 compared with NFs. The proliferation and migration capacities of CAFs were significantly lower after transfection with PD-L1-siRNA. The proliferation rate of HEP-2 cells cocultured with CAFs decreased in PD-L1-siRNA-transfected cells. However, the proliferation rate of T cells increased in transfected cells. The ELISA results showed that the secretion of IL-2 increased and that of IL-10 decreased in PD-L1-siRNA-transfected cells. The expression of PD-L1 in CAFs of advanced LSCC was higher than that in NFs. The downregulation of PD-L1 reduced the proliferation and migration of CAFs and HEP-2 cells but enhanced the proliferation and pro-inflammatory function of T cells in the coculture experiment.

摘要

本研究旨在探讨肿瘤相关成纤维细胞(CAFs)中程序性死亡配体 1(PD-L1)对晚期喉鳞状细胞癌(LSCC)的影响。通过免疫荧光显微镜观察 83 例 LSCC 患者的晚期 LSCC 肿瘤组织中 PD-L1 的表达,并与正常喉黏膜进行比较。分离、培养、纯化 LSCC 和正常成纤维细胞(NFs),并用荧光法进行鉴定。通过流式细胞术检测纯化后的 CAFs 和 NFs 中 PD-L1 的表达。通过小干扰 RNA(siRNA)转染下调 CAFs 中 PD-L1 的表达。通过增殖和划痕试验分别观察 CAFs 的增殖和迁移能力。将 CAFs 与 HEP-2 细胞和 T 细胞共培养后,测量 HEP-2 细胞和 T 细胞的增殖情况。采用酶联免疫吸附试验(ELISA)检测白细胞介素(IL)-2 和 IL-10 的分泌。在 83 例晚期 LSCC 肿瘤组织中,有 62 例表达 PD-L1。此外,CAFs 表达的 PD-L1 明显多于 NFs。转染 PD-L1-siRNA 后,CAFs 的增殖和迁移能力显著降低。与 CAFs 共培养的 HEP-2 细胞的增殖率在转染 PD-L1-siRNA 的细胞中降低,但转染细胞中 T 细胞的增殖率增加。ELISA 结果显示,转染 PD-L1-siRNA 的细胞中 IL-2 的分泌增加,IL-10 的分泌减少。晚期 LSCC 中 CAFs 表达的 PD-L1 高于 NFs。下调 PD-L1 可降低 CAFs 和 HEP-2 细胞的增殖和迁移能力,但在共培养实验中增强了 T 细胞的增殖和促炎功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/94227a322e0d/10.1177_15330338211046432-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/9039795d1ab8/10.1177_15330338211046432-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/fb121660d37c/10.1177_15330338211046432-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/3016fcbbf7b6/10.1177_15330338211046432-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/5ac6ad2ba2bf/10.1177_15330338211046432-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/2f7dc0731e19/10.1177_15330338211046432-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/21d1f01ef10f/10.1177_15330338211046432-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/94227a322e0d/10.1177_15330338211046432-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/9039795d1ab8/10.1177_15330338211046432-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/fb121660d37c/10.1177_15330338211046432-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/3016fcbbf7b6/10.1177_15330338211046432-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/5ac6ad2ba2bf/10.1177_15330338211046432-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/2f7dc0731e19/10.1177_15330338211046432-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/21d1f01ef10f/10.1177_15330338211046432-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd73/8504221/94227a322e0d/10.1177_15330338211046432-fig7.jpg

相似文献

1
Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma.程序性死亡配体 1 在癌相关成纤维细胞对晚期喉鳞状细胞癌的影响。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211046432. doi: 10.1177/15330338211046432.
2
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.PD-L1 阳性癌相关成纤维细胞在 pN0M0 非小细胞肺癌中的临床意义。
Lung Cancer. 2019 Nov;137:56-63. doi: 10.1016/j.lungcan.2019.09.013. Epub 2019 Sep 16.
3
APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma.APE1 促进喉和下咽鳞状细胞癌中 PD-L1 介导的进展。
Int Immunopharmacol. 2021 Aug;97:107675. doi: 10.1016/j.intimp.2021.107675. Epub 2021 May 6.
4
miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.miR-181a 通过靶向 GATA6 抑制人喉鳞状细胞癌的进展。
Future Oncol. 2018 Jul;14(17):1741-1753. doi: 10.2217/fon-2018-0064. Epub 2018 Mar 8.
5
Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1.癌相关成纤维细胞来源的外泌体 ZNF250 通过转录激活 PD-L1 促进肝癌细胞的增殖、迁移、侵袭和免疫逃避。
J Biochem Mol Toxicol. 2024 Sep;38(9):e23778. doi: 10.1002/jbt.23778.
6
[Study on the mechanism of miR-497-induced laryngeal squamous cell carcinoma growth inhibition by targeting CDK6].[miR-497通过靶向CDK6抑制喉鳞状细胞癌生长的机制研究]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Feb 7;54(2):126-132. doi: 10.3760/cma.j.issn.1673-0860.2019.02.006.
7
Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis.喉癌术后放疗。程序性死亡配体 1 的预后作用:基于免疫微环境的聚类分析。
Pathol Res Pract. 2020 Sep;216(9):153120. doi: 10.1016/j.prp.2020.153120. Epub 2020 Jul 13.
8
circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.环状 PAR 结构域蛋白 3 通过抑制自噬,经蛋白激酶 C Ⅰ-Akt-雷帕霉素靶蛋白通路促进喉鳞状细胞癌的恶性进展和化疗耐药。
Mol Cancer. 2020 Nov 24;19(1):166. doi: 10.1186/s12943-020-01279-2.
9
Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal.在人HEp-2建立的喉异种移植瘤中,癌症相关成纤维细胞并非通过上皮-间质转化源自癌细胞,其表型被激活但核型正常。
PLoS One. 2015 Feb 6;10(2):e0117405. doi: 10.1371/journal.pone.0117405. eCollection 2015.
10
Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma.X连锁锌指蛋白(ZFX)对人喉鳞状细胞癌患者的预后、细胞增殖和凋亡有影响。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):13886-99. eCollection 2015.

引用本文的文献

1
Emerging role of RNA m6A modifications in laryngeal squamous cell carcinoma: insights into tumorigenesis and therapeutic potential.RNA m6A修饰在喉鳞状细胞癌中的新兴作用:对肿瘤发生和治疗潜力的见解
Apoptosis. 2025 Aug 14. doi: 10.1007/s10495-025-02159-0.
2
Cancer and immune response: The role of PD-1/PD-L1 checkpoint in laryngeal carcinoma. Preliminary results.癌症与免疫反应:PD-1/PD-L1 检查点在喉癌中的作用。初步结果。
Eur Arch Otorhinolaryngol. 2024 Oct;281(10):5411-5417. doi: 10.1007/s00405-024-08822-7. Epub 2024 Jul 28.

本文引用的文献

1
The CD28-B7 Family of Co-signaling Molecules.CD28-B7 共刺激分子家族。
Adv Exp Med Biol. 2019;1189:25-51. doi: 10.1007/978-981-32-9717-3_2.
2
Expression of PD-L1 on Immune Cells Shows Better Prognosis in Laryngeal, Oropharygeal, and Hypopharyngeal Cancer.免疫细胞上PD-L1的表达在喉癌、口咽癌和下咽癌中显示出更好的预后。
Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):e79-e85. doi: 10.1097/PAI.0000000000000590.
3
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.
4
Tumor microenvironment and therapeutic response.肿瘤微环境与治疗反应。
Cancer Lett. 2017 Feb 28;387:61-68. doi: 10.1016/j.canlet.2016.01.043. Epub 2016 Feb 1.
5
Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.评估喉鳞状细胞癌中 PD-L1 表达及相关肿瘤浸润淋巴细胞。
Clin Cancer Res. 2016 Feb 1;22(3):704-13. doi: 10.1158/1078-0432.CCR-15-1543. Epub 2015 Sep 25.
6
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment.癌症相关成纤维细胞作为肿瘤微环境中另一种极化细胞类型。
Front Oncol. 2014 Mar 27;4:62. doi: 10.3389/fonc.2014.00062. eCollection 2014.
7
T4a laryngeal cancer survival: retrospective institutional analysis and systematic review.T4a期喉癌的生存率:机构回顾性分析与系统评价
Laryngoscope. 2014 Jul;124(7):1618-23. doi: 10.1002/lary.24557. Epub 2014 Jan 24.
8
Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.癌细胞与肿瘤微环境成分之间的分子串扰表明,在活动型舌癌中有新的治疗方法的潜在靶点。
Cancer Med. 2012 Oct;1(2):128-40. doi: 10.1002/cam4.24. Epub 2012 Aug 16.
9
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.PD-1:PD-L1 通路在 HPV 相关头颈部鳞状细胞癌免疫抵抗中的作用证据。
Cancer Res. 2013 Mar 15;73(6):1733-41. doi: 10.1158/0008-5472.CAN-12-2384. Epub 2013 Jan 3.
10
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.针对 PD-1/B7-H1(PD-L1)通路激活抗肿瘤免疫。
Curr Opin Immunol. 2012 Apr;24(2):207-12. doi: 10.1016/j.coi.2011.12.009. Epub 2012 Jan 9.